| Old Articles: <Older 46071-46080 Newer> |
|---|
 |
The Motley Fool
December 17, 2010
Brian Orelli |
An Overnight Double: Santa Visits InterMune in Europe The Committee for Medicinal Products for Human Use issued a positive recommendation for the approval of InterMune's idiopathic pulmonary fibrosis treatment, Esbriet, sending shares up 140%.   |
The Motley Fool
December 17, 2010
Rich Smith |
Upgrades and Downgrades and Updates (Oh My!) Goldman tweaks its estimates of Intuitive's prospects. |
The Motley Fool
December 17, 2010
Seth Jayson |
Does This Make Amphenol a Sell? Don't be surprised if there's trouble ahead for the diversified electronics company. |
The Motley Fool
December 17, 2010
Seth Jayson |
Why the Earnings at Amdocs Are Outstanding Over the past 12 months telecom software developer Amdocs turned 20% of its revenue into free cash flow. |
The Motley Fool
December 17, 2010
Matt Koppenheffer |
5 Holiday Gifts for the Investor on Your List Five stock gifts to make 2011 a more profitable year for your favorite investor. |
The Motley Fool
December 17, 2010
Anders Bylund |
Did RIM Drop the Torch or Not? Should you carry a Torch for RIM -- or get together with an even stronger rival instead? |
The Motley Fool
December 17, 2010
Seth Jayson |
Why John Wiley & Sons' Earnings Are Outstanding With 38.1% of operating cash flow coming from questionable sources, John Wiley & Sons investors should take a closer look at the underlying numbers. |
The Motley Fool
December 17, 2010
Seth Jayson |
Should You Get Out of International Flavors & Fragrances Before Next Quarter? The numbers don't paint a clear picture. For the last fully reported fiscal quarter, International Flavors & Fragrances' year-over-year revenue grew 9.9%, and its AR grew 7.3%. That looks OK. |
The Motley Fool
December 17, 2010
Seth Jayson |
West Pharmaceutical Services Passes This Key Test For the last fully reported fiscal quarter, West Pharmaceutical Services' year-over-year revenue grew 4.8%. |
The Motley Fool
December 17, 2010
Seth Jayson |
NICE Systems Passes This Key Test For the latest fully reported fiscal quarter, NICE Systems' year-over-year revenue grew 20.9%, and its AR grew 3.2%. That looks OK. |
| <Older 46071-46080 Newer> Return to current articles. |
